Effects of submucosally administered platelet-rich plasma on the rate of tooth movement

Saraa L Angel, Vilas D Samrit, Om Prakash Kharbanda, Ritu Duggal, Vikas Kumar, Shyam S Chauhan, Poonam Coshic, Saraa L Angel, Vilas D Samrit, Om Prakash Kharbanda, Ritu Duggal, Vikas Kumar, Shyam S Chauhan, Poonam Coshic

Abstract

Objectives: To evaluate the effects of submucosally administered platelet-rich plasma (PRP) on the rate of maxillary canine retraction. Levels of soluble receptor activator of nuclear factor-κb ligand (sRANKL) and osteoprotegerin (OPG) in the gingival crevicular fluid (GCF) were also measured over 2 months.

Materials and methods: This split-mouth trial involved 20 sites in 10 subjects randomly assigned to PRP (experimental) side and control side. After alignment, the freshly prepared PRP was injected submucosally distal to the experimental side maxillary canine, and retraction was performed using NiTi closed-coil springs (150 g) on 0.019 × 0.025-inch stainless steel wire. The rate of canine movement was assessed using digital model superimposition at 0, 30, and 60 days. The OPG and sRANKL were assayed using enzyme-linked immunosorbent assay from GCF collected at 0, 1, 7, 21, 30, and 60 days.

Results: Twenty sites were analyzed using paired t test. The rate of tooth movement increased significantly by 35% on the PRP side compared with the control side in the first month (P = .0001) and by 14% at the end of the second month (P = .015). Using the Mann-Whitney U test, OPG levels were found to be significantly decreased on the 7th (P = .003) and 30th day on the PRP side (P = .01), while sRANKL became detectable by the third week postinjection on the PRP side (P = .069).

Conclusions: Submucosal injection of platelet-rich plasma significantly increased tooth movement during the 60-day observation period. Local injection of PRP significantly altered the levels of OPG and sRANKL in GCF.

Keywords: 3D superimposition; Acceleration; PRP.

© 2022 by The EH Angle Education and Research Foundation, Inc.

Figures

Figure 1.
Figure 1.
Rugae points used for superimposition.
Figure 2.
Figure 2.
CONSORT flowchart.
Figure 3.
Figure 3.
Amount of canine retraction in the control and platelet-rich plasma group over 60 days.
Figure 4.
Figure 4.
Comparison of osteoprotegerin levels in control and platelet-rich plasma group.
Figure 5.
Figure 5.
Comparison of soluble receptor activator of nuclear factor-κb ligand L levels in control and platelet-rich plasma group.

References

    1. Alansari S, Sangsuwon C, Vongthongleur T, et al. Biological principles behind accelerated tooth movement. Semin Orthod . 2015;21:151–161.
    1. Long H, Pyakurel U, Wang Y, Liao L, Zhou Y, Lai W. Interventions for accelerating orthodontic tooth movement. A systematic review. Angle Orthod . 2013;83:164–171.
    1. Keser EI, Dibart S. Sequential piezocision: a novel approach to accelerated orthodontic treatment. Am J Orthod Dentofacial Orthop . 2013;144:879–889.
    1. Alikhani M, Raptis M, Zoldan B, et al. Effect of micro-osteoperforations on the rate of tooth movement. Am J Orthod Dentofacial Orthop . 2013;144:639–648.
    1. Liou EJ. The development of submucosal injection of platelet rich plasma for accelerating orthodontic tooth movement and preserving pressure side alveolar bone. APOS Trends Orthod . 2016;6:5–11.
    1. Yamasaki K, Shibata Y, Imai S, Tani Y, Shibasaki Y, Fukuhara T. Clinical application of prostaglandin E1 upon orthodontic tooth movement. Am J Orthod . 1984;85:508–518.
    1. Sekhavat AR, Mousavizadeh K, Pakshir HR, Aslani FS. Effect of misoprostol, a prostaglandin E1 analog, on orthodontic tooth movement in rats. Am J Orthod Dentofacial Orthop . 2002;122:542–547.
    1. Soma S, Matsumoto S, Higuchi Y, et al. Local and chronic application of PTH accelerates tooth movement in rats. J Dent Res . 2000;79:1717–1724.
    1. Collins MK, Sinclair PM. The local use of vitamin D to increase the rate of orthodontic tooth movement. Am J Orthod Dentofacial Orthop . 1988;94:278–284.
    1. Molina Da Silva GP, Tanaka OM, Campos Navarro DF, et al. The effect of potassium diclofenac and dexamethasone on MMP-1 gene transcript levels during experimental tooth movement in rats. Orthod Craniofac Res . 2017;20:30–34.
    1. Seifi M, Badiee MR, Abdolazimi Z, Amdjadi P. Effect of basic fibroblast growth factor on orthodontic tooth movement in rats. Cell J . 2013;15:230–237.
    1. Hashimoto F, Kobayashi Y, Mataki S, Kobayashi K, Kato Y, Sakai H. Administration of osteocalcin accelerates orthodontic tooth movement induced by a closed coil spring in rats. Eur J Orthod . 2001;23:535–545.
    1. Almpani K, Kantarci A. Nonsurgical methods for the acceleration of the orthodontic tooth movement. Front Oral Biol . 2016;18:80–91.
    1. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg . 2004;62:489–496.
    1. Sanchez AR, Sheridan PJ, Kupp LI. Is platelet-rich plasma the perfect enhancement factor? A current review. Int J Oral Maxillofac Implants . 2003;18:93–103.
    1. El-Sharkawy H, Kantarci A, Deady J, et al. Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. J Periodontol . 2007;78:661–669.
    1. Gulec A, Bakkalbasi BC, Cumbul A, Uslu U, Alev B, Yarat A. Effects of local platelet-rich plasma injection on the rate of orthodontic tooth movement in a rat model: a histomorphometric study. Am J Orthod Dentofacial Orthop . 2017;151:92–104.
    1. Kanzaki H, Makihira S, Suzuki M, et al. Soluble RANKL cleaved from activated lymphocytes by TNF-α–converting enzyme contributes to osteoclastogenesis in periodontitis. J Immunol . 2016;197:3871–3883.
    1. Schoppet M, Preissner KT, Hofbauer LC. RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function. Arterioscler Thromb Vasc Biol . 2002;22:549–553.
    1. Gonshor A. Technique for producing platelet-rich plasma and platelet concentrate: background and process. Int J Periodontics Restorative Dent . 2002;22;:547–557.
    1. Graziani F, Ivanovski S, Cei S, Ducci F, Tonetti M, Gabriele M. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin Oral Implants Res . 2006;17:212–219.
    1. Choi BH, Zhu SJ, Kim BY, Huh JY, Lee SH, Jung JH. Effect of platelet-rich plasma (PRP) concentration on the viability and proliferation of alveolar bone cells: an in vitro study. Int J Oral Maxillofac Surg . 2005;34:420–424.
    1. Peerbooms JC, Colaris JW, Hakkert AA, et al. No positive bone healing after using platelet rich plasma in a skeletal defect: an observational prospective cohort study. Int Orthop . 2012;36:2113–2119.
    1. Nakornnoi T, Leethanakul C, Samruajbenjakun B. The influence of leukocyte-platelet-rich plasma on accelerated orthodontic tooth movement in rabbits. Korean J Orthod . 2019;49:372–380.
    1. Fufa D, Shealy B, Jacobson M, Kevy S, Murray MM. Activation of platelet-rich plasma using soluble type I collagen. J Oral Maxillofac Surg . 2008;66:684–690.
    1. Hoggan BR, Sadowsky C. The use of palatal rugae for the assessment of anteroposterior tooth movements. Am J Orthod Dentofacial Orthop . 2001;119:482–488.
    1. Bailey LT, Esmailnejad A, Almeida MA. Stability of the palatal rugae as landmarks for analysis of dental casts in extraction and non-extraction cases. Angle Orthod . 1996;66:73–78.
    1. Jang I, Tanaka M, Koga Y, et al. A novel method for the assessment of three-dimensional tooth movement during orthodontic treatment. Angle Orthod . 2009;79:447–453.
    1. El-Timamy A, El-Sharaby F, Eid F, El-Dakroury A, Mostafa Y, Shaker O. Effect of platelet-rich plasma on the rate of orthodontic tooth movement. Angle Orthod . 2020;90:354–361.
    1. Rashid A, El-Sharaby FA, Nassef EM, Mehanni S, Mostafa YA. Effect of platelet-rich plasma on orthodontic tooth movement in dogs. Orthod Craniofac Res . 2017;20:102–110.
    1. Akbulut S, Yagci A, Yay AH, Yalcin B. Experimental investigation of effects of platelet-rich plasma on early phases of orthodontic tooth movement. Am J Orthod Dentofacial Orthop . 2019;155:71–79.
    1. Nishijima Y, Yamaguchi M, Kojima T, Aihara N, Nakajima R, Kasai K. Levels of RANKL and OPG in gingival crevicular fluid during orthodontic tooth movement and effect of compression force on releases from periodontal ligament cells in vitro. Orthod Craniofac Res . 2006;9:63–70.
    1. Toygar HU, Kircelli BH, Bulut S, Sezgin N, Tasdelen B. Osteoprotegerin in gingival crevicular fluid under long-term continuous orthodontic force application. Angle Orthod . 2008;78:988–993.
    1. Low E, Zoellner H, Kharbanda OP, Darendeliler MA. Expression of mRNA for osteoprotegerin and receptor activator of nuclear factor kappa β ligand during root resorption induced by the application of heavy orthodontic forces on rat molars. Am J Orthod Dentofacial Orthop . 2005;128:497–503.
    1. Kapoor P, Kharbanda OP, Monga N, Miglani R, Kapila S. Effect of orthodontic forces on cytokine and receptor levels in gingival crevicular fluid: a systematic review. Prog Orthod . 2014;15:65.
    1. Sakellari D, Menti S, Konstantinidis A. Free soluble receptor activator of nuclear factor-κb ligand in gingival crevicular fluid correlates with distinct pathogens in periodontitis patients. J Clin Periodontol . 2008;35:938–943.
    1. Lloyd SAJ, Yuan YY, Kostenuik PJ, et al. Soluble RANKL induces high bone turnover and decreases bone volume, density, and strength in mice. Calcif Tissue Int . 2008;82:361–372.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner